Cytogenetic prioritization with inclusion of molecular markers predicts outcome in previously untreated patients with chronic lymphocytic leukemia treated with fludarabine or fludarabine plus cyclophosphamide: a long-term follow-up study of the US intergroup phase III trial E2997

Export metadata

Statistics

Number of document requests

Additional Services

Share in Twitter Search Google Scholar
Metadaten
Author:David M. Lucas, Amy S. Ruppert, Gerard Lozanski, Gordon W. Dewald, Arletta Lozanski, Rainer ClausGND, Christoph Plass, Ian W. Flinn, Donna S. Neuberg, Elisabeth M. Paietta, John M. Bennett, Diane F. Jelinek, John G. Gribben, Mohamad A. Hussein, Frederick R. Appelbaum, Richard A. Larson, Dennis F. Moore, Martin S. Tallman, John C. Byrd, Michael R. Grever
Frontdoor URLhttps://opus.bibliothek.uni-augsburg.de/opus4/89181
ISSN:1042-8194OPAC
ISSN:1029-2403OPAC
Parent Title (English):Leukemia & Lymphoma
Publisher:Informa UK Limited
Type:Article
Language:English
Year of first Publication:2015
Release Date:2021/09/20
Tag:Cancer Research; Oncology; Hematology
Volume:56
Issue:11
First Page:3031
Last Page:3037
DOI:https://doi.org/10.3109/10428194.2015.1023800
Institutes:Medizinische Fakultät
Medizinische Fakultät / Universitätsklinikum
Medizinische Fakultät / Professur für personalisierte Tumormedizin und molekulare Onkologie